Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Julian
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   34    
Direct Shares   1,043,405    

Indirect Shares

   242,109,977      
Direct Value   $77,034,835    

Indirect Value

   $16,212,584,657      
Total Shares   243,153,382      
Total Value   $16,289,619,492      


Incyte Corp $35,333,665 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,209,731 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,146,330 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $563,030 Incyte Corp $35,333,665 Neurogene $16,634 Acadia Pharmaceuticals Inc $3,209,731 Aceragen, Inc $16,666 Mirati Therapeutics, Inc. $16,084 Beigene Ltd $3,146,330 Seagen Inc $10,649,448 Alexion Pharmaceuticals Inc $24,083,248 Kiniksa Pharmaceuticals, Ltd. $563,030
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    46   
    7    

     Stock price went up :
    23   
    7    
     Stock price went down :
    23   
    0    
   
     Gain/Loss Ratio :
   0.0   
   7.0   
     Percentage Gain/Loss :
   11.8%
 80.1%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA 10% Owner 2003-09-26 0 2011-11-02 144,082    Premium*  
            Innoviva Inc INVA Director 2005-12-13 0 2004-10-04 33,839    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2004-10-13 0 2011-06-30 4,045,398    Premium*  
            Incyte Corp INCY 2024-06-12 559,963 2024-06-12 28,216,015    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2019-08-29 0 2019-08-29 9,262,659    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 2009-01-23 0 2009-01-23 2,258    Premium*  
            Viropharma Inc VPHM 10% Owner 0 2011-12-14 9,840,469    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2009-10-19 5,264,782    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2012-01-27 0    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 2011-08-22 0 2012-02-10 557,211    Premium*  
            XOMA Corporation XOMA Former 10% owner 0 2015-07-22 90,538    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 3,540,015    Premium*  
            Neurogene NGNE Director 2020-07-07 4,520 2020-07-07 3,501,691    Premium*  
            Acadia Pharmaceuticals Inc ACAD 2024-05-29 205,752 2024-05-29 39,349,751    Premium*  
            Invitae Corp NVTA 10% Owner 2018-03-28 0 2018-03-28 7,553,553    Premium*  
            Aceragen, Inc ACGN 10% Owner 2019-07-01 43,858 2019-07-01 4,290,995    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM Former 10% owner 2017-10-05 0 2017-10-05 1,878,242    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2017-11-08 274 2017-11-08 35,999    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2018-01-17 0 2018-01-19 58,131    Premium*  
            Beigene Ltd BGNE 2024-06-05 20,838 2024-06-05 10,694,996    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2021-05-14 46,557 2021-05-14 43,309,073    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2020-05-14 131,963 2020-05-14 7,940,623    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-06-05 29,680 2024-06-05 2,725,689    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2018-10-09 0 2021-09-30 13,526,726    Premium*  
            Atreca Inc BCEL 10% Owner 2019-06-24 0 2019-06-24 3,223,030    Premium*  
            Igm Biosciences, Inc. IGMS Director, 10% Owner 2019-09-20 0 2021-01-27 2,895,306    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2021-01-27 9,252,951    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 0 2021-01-01 4,286,038    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 0 2021-02-17 7,003,766    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE Director 0 2021-02-23 3,410,106    Premium*  
            Tscan Therapeutics, Inc. TCRX Director 2021-07-20 0 2021-07-20 1,320,302    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 0 2021-12-14 4,704,419    Premium*  
            Bicycle Therapeutics Ltd BCYC 0 2024-06-17 8,636,006    Premium*  
            Immunocore Holdings Adr IMCR 0 2024-05-28 1,515,318    Premium*  
* Premium Members only  

Records found :    503         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 16 of 21
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp Director   –       •      –    2007-11-09 4 B $7.70 $1,560,590 I/I 202,512 1,932,500 2.1 -
GHDX Genomic Health Inc Director   –       •      –    2006-12-05 4 B $22.55 $1,578,459 I/I 70,010 1,197,377 2.1 -
INCY Incyte Corp Director   –       •      –    2007-11-27 4 B $8.00 $1,584,549 I/I 198,138 3,324,193 2.1 -
GHDX Genomic Health Inc Director   –       •       •   2005-10-04 4 B $12.00 $1,635,792 I/I 136,316 252,529 2.25 -
INCY Incyte Corp Director   –       •       •   2007-12-12 4 B $10.38 $1,770,750 I/I 170,512 4,039,099 2.25 -
XOMA XOMA Corporation Director   –       •       •   2014-12-09 4 S $4.62 $1,811,062 I/I (392,353) 465,335 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-24 4 B $51.41 $1,873,924 I/I 36,020 11,280,001 2.25 %
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-10-13 4 D $35.40 $1,963,178 I/I (55,457) 23,708,408 0 -
ACAD Acadia Pharmaceuticals In... Director   –       •       •   2017-10-13 4 OE $1.38 $1,968,694 I/I 1,426,590 23,763,865 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2021-08-18 4 B $87.79 $1,984,806 I/I 22,584 13,128,006 2.25 %
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-28 4 B $13.32 $2,001,154 I/I 150,007 7,288,185 1.5 -
XOMA XOMA Corporation Director   –       •       •   2014-12-15 4 S $4.45 $2,050,652 I/I (460,800) 449,970 0 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2017-11-08 4 OE $7.86 $2,202,867 I/I 280,263 35,999 0 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-17 4 S $8.63 $2,247,910 I/I (260,600) 66,815 0 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2011-11-29 4 B $14.12 $2,300,343 I/I 162,271 7,450,456 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-25 4 B $18.43 $2,326,615 I/I 125,551 8,330,655 1.5 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-19 4 S $7.91 $2,336,217 I/I (295,361) 58,131 0 -
OCRX Ocera Therapeutics Inc 10% Owner   –       –       •   2012-03-12 4 B $1.87 $2,341,269 I/I 961,299 3,290,162 1.5 -
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-24 4 B $17.86 $2,357,591 I/I 131,311 8,205,104 1.5 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-09-30 4 B $18.08 $2,391,014 I/I 131,978 8,841,213 1.5 -
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2018-01-18 4 S $8.12 $2,635,768 I/I (324,774) 62,267 0 -
VPHM Viropharma Inc 10% Owner   –       –       •   2011-10-05 4 B $18.18 $2,650,423 I/I 145,763 9,548,763 1.5 -
XOMA XOMA Corporation Director   –       •       •   2014-12-02 4 S $5.36 $2,679,550 I/I (500,000) 513,815 0 -
KOD Kodiak Sciences Inc. Director   –       •       •   2020-09-25 4 B $55.35 $2,726,182 I/I 48,125 11,324,937 2.25 %
PCYC Pharmacyclics Inc 10% Owner   –       –       •   2012-01-23 4 B $16.84 $2,737,009 I/I 162,215 8,073,793 1.5 -
  503  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16  17   18   19   20   21      
  Page 16 of 21  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us